MRK Financial Facts

Total Costs, Expenses and Other: 12.82B
Restructuring costs: 545.6M
See Full Income Statement

Cash and cash equivalents: 6.63B
Trade accounts payable: 646.8M
See Full Balance Sheet

Merck & Co. Inc. (MRK) Earnings

  |   Expand Research on MRK
Next EPS Date 7/29/16 EPS Growth Rate +5.8%
Average EPS % Beat Rate +4.4% Revenue Growth Rate -0.1%
Average % Move 1-Wk after EPS +0.2% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/29/16 Q216 N/A$0.91 N/A N/A$9.79B N/A N/A N/A
5/5/16 Q116 $0.89$0.85 +$0.04$9.3B$9.46B N/A Details
2/3/16 Q415 $0.93$0.91 +$0.02$10.22B$10.35B N/A Details
10/27/15 Q315 $0.96$0.92 +$0.04$10.1B$10.11B Details
7/28/15 Q215 $0.86$0.81 +$0.05$9.8B$9.8B Details
4/28/15 Q115 $0.85$0.74 +$0.11$9.4B$9.04B Details
2/4/15 Q414 $0.87$0.86 +$0.01$10.48B$10.61B Details
10/27/14 Q314 $0.90$0.88 +$0.02$10.56B$10.66B = Details